Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05188235 · ClinicalTrials.gov registry record · NA
Sound Conduction of Infant Hips
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT05188235 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 61 participants.
The verdict
NCT05188235, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The objective of this study is to collect data that will be used to later design a method for the early diagnosis of diagnosis of developmental dysplasia of the hip (DDH).
Interventions
- DEVICE Acoustical Resonance Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2022-03-10 |
| Est. Completion | 2023-10-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05188235
The ClinicalTrials.gov registry entry for NCT05188235 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acoustical Resonance Device is the first listed.
NCT05188235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05188235 about?
NCT05188235 is a clinical study titled "Sound Conduction of Infant Hips". The objective of this study is to collect data that will be used to later design a method for the early diagnosis of diagnosis of developmental dysplasia of the hip (DDH).
What is the current status of trial NCT05188235?
This trial is currently terminated. It is a NA study. The enrollment target is 61 participants. The study started on 2022-03-10. Estimated completion is 2023-10-06.
What interventions are being tested in trial NCT05188235?
The interventions under investigation include: Acoustical Resonance Device (DEVICE).
Who is sponsoring clinical trial NCT05188235?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.